Ped-CPA: Pediatric Out-of-hospital Cardiopulmonary Arrest

Sponsor
Centre Hospitalier Régional Metz-Thionville (Other)
Overall Status
Completed
CT.gov ID
NCT05474131
Collaborator
Hospices Civils de Lyon (Other)
137
1
38.4
3.6

Study Details

Study Description

Brief Summary

The objective of this observational and retrospective study is to determine the predictive factors of in-hospital mortality following an out-of-hospital cardiopulmonary arrest (CPA) in the population under 18 years old. Data are collected from telephone calls and medical regulation records processed by the health call center of 2 french departments between January 1, 2019, and March 15, 2022. The medical records of the included patients will also be reread in order to obtain the patient's status at 30 days after the CPA.

Detailed description:

The literature reports numerous works evaluating the epidemiological characteristics of pediatric out-of-hospital cardiorespiratory arrest. An improvement in survival has been reported in the case of resuscitation guided by the operator in medical regulation before the arrival of the emergency services. Indeed, the regulation phase at the 15 center in France is of fundamental importance. Recent evolutions, notably with the creation of specific call-taking professions, show the importance attached to improving practices.

The population concerned is characterized by children under 18 years of age, victims of an extra-hospital cardiorespiratory arrest. It is a retrospective study over three years and three months, multicentric, from the emergency service (SAMU) 57 and 69.

The primary endpoint was the all-cause mortality at thirty days of the admission.

The case report form (CRF) will collect the main aspects of telephone management at the 15 centers, out-of-hospital management by the emergency teams, and the personal characteristics of the emergency physicians and out-of-hospital responders (gender, age, family situation, etc.). The medical management in the emergency department and the first stages of in-hospital management will also be analyzed. The patients included who are still alive will receive a notification of non-objection by mail.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    137 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Pediatric Out-of-hospital Cardiopulmonary Arrest, Current Status of Out-of-hospital Management, Predictive Factors of Mortality, Physicians' Attitudes, Training Perspectives : a Multicentric Retrospective Study.
    Actual Study Start Date :
    Jan 1, 2019
    Actual Primary Completion Date :
    Mar 15, 2022
    Actual Study Completion Date :
    Mar 15, 2022

    Outcome Measures

    Primary Outcome Measures

    1. death from any cause within thirty days of admission [at day 30]

      The vital status at Day 30 will be systematically sought.

    Secondary Outcome Measures

    1. Resuscitation in pre-hospital care during the listening of the sound tapes of the SAMU [at day 1]

      The resumption of a spontaneous cardiac activity will be sought during the listening of the sound tapes of the SAMU

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 17 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • child under 17 years old

    • and call for cardiac arrest or cardiac arrest detected on call

    Exclusion Criteria:
    • non-real cardiac arrest

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHR Metz-Thionville/Hopital de Mercy Metz France 57085

    Sponsors and Collaborators

    • Centre Hospitalier Régional Metz-Thionville
    • Hospices Civils de Lyon

    Investigators

    • Principal Investigator: Laure ABENSUR VUILLAUME, PhD, MD, CHR Metz Thionville Hopital de Mercy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Régional Metz-Thionville
    ClinicalTrials.gov Identifier:
    NCT05474131
    Other Study ID Numbers:
    • 2022-07Obs-CHRMT
    First Posted:
    Jul 26, 2022
    Last Update Posted:
    Jul 28, 2022
    Last Verified:
    Jul 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 28, 2022